Discrimination may speed up the biological processes of aging, according to a new study led by researchers at the NYU School of Global Public Health.
The leading TV ad-spending drug brand is getting a campaign refresh for one of its indications. Sanofi and Regeneron renewed the effort for Dupixent in
Vertex will pay $25 million upfront for TreeFrog Therapeutics’ cell manufacturing technology that can help boost production of its early-phase type 1 diabetes assets. In